STABLIX
Live / Allowed — Notice of allowance issued (as of 20 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99206364
- Mark type
- Stylized text
- Filed
- 28 May 2025
- Published for opposition
- 25 Nov 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the restoration of protein stability and function; Pharmaceutical preparations comprising small molecules for stabilizing cellular proteins to restore normal function and treat disease; pharmaceutical preparations for targeted protein stabilization
- Class 042 — Scientific and technological services: Pharmaceutical products development of new small molecules aimed at stabilizing cellular proteins to restore normal function and treat disease; research and development of therapeutic modalities for treatment of diseases; research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; research and development services in the field of protein stabilization therapeutics
Owner
- Stablix, Inc., Boston, MA, US
- Stablix, Inc., Boston, MA, US
Prosecution history
- 20 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Oct 2025 — ASSIGNED TO EXAMINER
- 05 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 May 2025 — APPLICATION FILING RECEIPT MAILED
- 28 May 2025 — NEW APPLICATION ENTERED